Navigation Links
Agendia Appoints New Chief Financial Officer
Date:1/8/2009

HUNTINGTON BEACH, California, and AMSTERDAM, January 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Kurt Schmidt, CPA, MBA, as the company's new Chief Financial Officer.

"Kurt is an exceptional addition to our team and an invaluable asset," said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With his extensive financial management experience in the high tech and healthcare industries, he will be instrumental in driving Agendia's next phase of growth."

Mr. Schmidt succeeds former Chief Financial Officer, John de Die, who has been an exemplary guide for Agendia during his tenure. Mr. Schmidt brings more than 25 years of financial, operational and entrepreneurial management experience, primarily in the high tech and healthcare industries in the U.S. and Europe. Most recently, he was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services. Prior to that, Mr. Schmidt served as Operations Director at B2eMarkets, a supply chain technology company, and Director of Finance & Operations at LA Gear Europe. Mr. Schmidt started his career at Cardinal Health, Inc. in corporate finance.

"I am delighted to join Agendia during this exciting time and help prepare the company for our next financing round. I look forward to our first investor meetings next week during the JP Morgan Healthcare Conference in San Francisco," commented Kurt Schmidt, Chief Financial Officer.

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Agendia was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit http://www.agendia.com.


'/>"/>
SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
2. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
3. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
4. Agendia BV Appoints Clinical and Scientific Advisory Board
5. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
6. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
7. Agendia Joins the Personalized Medicine Coalition (PMC)
8. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
9. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
10. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
11. Algeta Appoints Andrew Kay as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... ... 18, 2017 , ... Lajollacooks4u has added another option for ... team-building package designed for groups of 10-30 people. Guests can choose their ... such as Blackened Shrimp with Edamame Salad, Pizza Rolls with Pepperoni and Mushrooms ...
(Date:5/18/2017)... , ... May 17, 2017 , ... NDA Partners Chairman ... and former CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit ... his position at Eurofins and Cardinal Health, he was former Chief Operating Officer at ...
(Date:5/18/2017)... ... May 17, 2017 , ... Cognition Corporation ... has just released version 9.0 of the Cognition Cockpit platform. , “Our whole ... says David Cronin, CEO of Cognition. “We’re thrilled to finally be able to ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... for varying industries, including food and dairy, munitions, and pharmaceutical/biotech, recently introduced The ... and ease of use. The improvement in technology comes on the heels of ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/16/2017)... -- CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog ... Used combined in one project, multi-biometric solutions provide ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):